Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
TAOISEACH MICHEÁL MARTIN has told the Dáil that a high-level taskforce has been established to oversee the roll out of Covid-19 vaccines in Ireland once they are approved by the statutory authorities.
Martin said that targeting people who are most vulnerable to Covid-19 will be the immediate priority of government.
The high-level vaccine task force will be tasked with co-ordinating preparations and ensuring the nationwide roll out of a Covid-19 vaccine when one is safe and ready to be distributed, said Martin.
In August, the government set up a vaccine strategy committee under the chairmanship of the Department of Health, while the HSE set up its own group.
However, Cabinet decided yesterday that a “whole-of-government group”, which will take in expertise from outside government in regard to organising the logistical operations, is now needed.
Who is on the taskforce?
The group will be chaired by Professor Brian MacCraith from DCU. The Chief Medical Officer Tony Holohan will also be on vaccine task force, as will Paul Reid, CEO of the HSE.
Senior civil servant and chair of the senior officials group on Covid-19, Liz Canavan, Barry Lowry, Government chief information officer; and Paul Quinn, Government chief procurement officer, will also sit on the taskforce.
Advertisement
In addition, there will be a nominee yet to be confirmed from the Department of Business, Enterprise and Innovation, who will be a logistics cold chain expert and a project management expert.
Earlier this week, Pfizer and BioNTech announced that their Covid-19 vaccine was 90% effective in its large-scale Phase 3 trial.
It has been hailed as a ‘watershed moment’ and welcomed by scientists, health officials and world leaders.
The vaccine requires two doses. This means twice the number of visits to a vaccination centre – or wherever it is administered. At best this would result in resource and administrative challenges in first world countries, but it presents a much more serious barrier for less developed countries.
Another serious roadblock is the temperature at which this vaccine needs to be stored: at -80 degrees.
This issue was raised by Labour leader Alan Kelly today in the Dáil.
The Taoiseach said Kelly was correct in identifying the logistical issues around the Pfizer-BioNTech vaccine in terms of the requirement for storage. He said the high-level vaccine task force will be tasked with co-ordinating preparations in this area.
Vaccines under consideration
However, Martin said it is not the only vaccine in the works.
He explained that Ireland is part of a pre-purchase agreement with the European Commission.
Related Reads
Pfizer 'cautiously optimistic' about getting vaccine approval by the end of November
Over half of people in Ireland would take a Covid-19 vaccine
Allocation of access to vaccine doses between Member States will be decided according to a set population distribution.
There are currently no Covid-19 vaccines authorised for use in Europe, but there is a portfolio of seven potential vaccines, explained the Taoiseach.
Advance Purchase Agreements have issued for three of these vaccines, and Ireland has opted-in to each. These include:
AstraZeneca, which is partnering with Oxford University
Janssen (owned by Johnson & Johnson)
Sanofi Pasteur – this will be formalised when the current phase of clinical trials of the vaccine have been completed (expected late December/early January).
The Taoiseach said the emerging news is that the Commission is on the cusp of signing, if it has not already signed, a deal with Pfizer and BioNTech.
“The President of the Commission has been leading that process and I have been in contact with her on it. It has been discussed at European Council meetings. Ultimately, it is the Commission’s target to have an agreement with seven consortia.
“There is enough funding across the European system for arrangements with six consortia and it will probably go to a seventh. We will need the full range of options throughout 2021 because the next issue will be manufacture.
“All of those agreements include specific dosage allocations that mean we would get approximately 1% of whatever the European procurement is… That will be very significant for us in terms of targeting the vulnerable and those who would be a priority in terms of the receipt of a vaccine,” said Martin.
Last month, a survey showed that over half of people in Ireland would take a Covid-19 vaccine if there was one.
The survey, conducted by Ipsos MRBI for the Irish Pharmaceutical Healthcare Association (IPHA) found 55% would take the vaccine, while 33% said they were unsure. 12% of respondents said they would not take a vaccine.
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
To embed this post, copy the code below on your site
Close
54 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic.
Please familiarise yourself with our comments policy
here
before taking part.
@bmul: canb jobs or extra work and maybe even extra work for no pay.
See most top civil servants are paid for the job they do and not by hours or time spend on boards and they would not normally get overtime either they are responsible 24/7/365 and not just the hours of 9 to 5.
So I am curious how much this might or might not be extra work and for how much, if any, extra income.
Even if there is money to be paid, this is what happens in many industries, so why not pay the experts if that is what is needed. It is open to anyone to join the public service and apply to take on the responsibility of dealing with issues that affect peoples lives, to get involved instead of sitting and commenting from the side lines. I am glad I do not have to made decisions that could affect whether someone lives or dies.
@Tommy Roche: please point out where I said I was against vaccines in general? Pandemrix swine flu vaccine was used here after being rushed to market. It later emerged it caused narcolepsy in some people. Why is it that you either are all for the vaccine to be given ASAP or you are anti-vax? Do people have no idea of nuance?
@Tommy Roche: Joe Moore is just sad he won’t have as many opportunities to poke fun at people dying. Thought he was very funny mocking people who died.
@Adam Conroy: when they can’t argue against the evidence they will try to smear the source. Best to just ignore anybody that throws around the anti-vaxxer label. They don’t seem capable of debating the evidence. Even when it comes from our current CMO. If they can’t acknowledge past mistakes, they are doomed to repeat them
@Tommy Roche: there’s no slowly outing with that lot. They are more delighted than anyone there’s a vaccine as they can shout from the rooftops about how their not taking it to seem edgy, despite it being optional and nobody caring about their personal choice.
@Evan: Again…Nobody on this thread has mentioned being anti-vax. I get the flu vaccine every year. But vaccine side effects are a real thing and we have recent evidence of them happening. It’s just as bad to stick your head in the sand about possible vaccine side effects as it is to be against vaccines completely.
@Anna Anna: I debate you but first you need to explain how this vaccine is the same as the H1N1 that caused issues.
Its easy for people like you a noted cutter and paster, to feel you have the credentials to use the issues experienced 11 years ago are going to repeat themselves.
There is a raft of evidence freely available right now on the differences but perhaps reading that might have you understand the difference in these two vaccines.
So, let’s begin how do you know the issues of the H1N1 vaccine will repeat themselves?
Pfizer was not involved in that btw, also Pfizer is now a global producer of vaccines and has many vaccines in the market, for example prenvar, initially a pediatric vaccine to prevent pneumonia in children and it has a safety record of 99% with billions of units produced.
Pfizers production and safety of vaccines is world renowned and the global team they have are some of the best in the industry.
Albert Burola, CEO of Pfizer stated repeatedly since July that no vaccine will be in the market if not safe, also all participants in the trial are going to be monitored for 2 years.
Vaccines will always have side effects some severe but mostly mild.
Over 500,000 people globally have participated in trails , largest in human history, some people, 10 reported, have had serious side effects, .
Now tell us why this vaccine is dangerous or more dangerous than the one 11 years ago.
@Adam Conroy: I’m not talking about reasonable people who have concerns about a quick vaccine. Thats understandable, I’m taking about people who make comments like having to be tied down with restraints to take it and other such hyperbolic statements as if they’ll be forced or something as if they are railing against some totalitarian regime or something. The oridinary Joe soap probably won’t even get it for 2 years and even then it will be optional. They care more about peoples reaction to them not taking it rather than just not taking it and leaving it up to everyone’s personal choice.
@Adam Conroy: What are the side-effects of this vaccine ? Why do people continue to drag up an incident involving one vaccine from one manufacturer 11yrs ago that caused issues in a tiny minority of those given the vaccine ? Anti-vaxxers never bring up the Polio vaccine, the measles vaccine, the mumps vaccine, the millions of doses of seasonal flu vaccine administered in Europe every year. And why ? Because they are safe !! Mentioning them would work against the agenda And by the way, I’m not sure why my comment didn’t include the name of the person I was replying to, but it wasn’t aimed directly at you.
@Tommy Roche: fair enough. But they’re talking about the one that caused side effects because it was rushed to use. All I’m saying is that I’d personally rather wait a year or two to see if this one will be completely safe. If it is in two years then sign me up.
@Metaljester: Why ? Are you content to keep exposing yourself to the virus? I assume there will be some sort of certificate when someone is vaccinated that can then be used to travel etc.
@Hector Son: I’ll gladly bring my yellow vaccine passport to get it dated & stamped to show I’ve got it. Along with all the other ones I’ve got for travel to other counties.
@Derek Anderson: When H5N1 finally evolves to make human to human transmission much easier, I guarantee you’ll be swatting people out of the way to get to the head of the queue. 40%-60% mortality rate and age is not a factor. Covid is only a taster of what viral evolution can throw at us.
Look, if they need a test person I would go for it if it means that I would be allowed to listen to live music, visit people, do sports, being in the nature… and if course travelling (first to my family)
well I guess those with the vaccine will not be subject to travel restrictions or pre flight tests or isolation upon arrival… great news for some,
We can have a covid-19 vaccine book just like we have for Yellow Fever – just imagine a vaccine was required to enter Spain and one arrived without their vaccination card and had to be vaccinated on the spot or sent packing home to Ireland… you think I joke – read the list of countries that may require a Yellow Fever Passport – https://www.who.int/ith/ITH_country_list.pdf – look it up I have a Yellow Fever Passport and I can see covid-19 vaccines going this way for a few years until the world has some level of immunity.
@Niall Ó Cofaigh: so can I, I have quiet a few vaccines in my yellow passport from my travels. I’ll happily get another one. To me the vaccine is going to equal freedom.
Do we have any idea how long this vaccine will give immunity for? It appears from the Imperial College study that those who tested positive for Covid 19 do not have detectable antibodies after 3-4 months so it’s not as if the vaccine will be giving immunity for a decent length of time in which case it won’t be the silver bullet people are hoping it will be but it sure will cost a lot.
JD Vance says US take over of Greenland ‘makes sense’ during scaled back visit
Updated
27 mins ago
26.8k
80
Ceann Comhairle
Verona Murphy has ‘full’ government support and opposition needs to ‘get on with it’
39 mins ago
910
10
Courts
Garda superintendent appears in court accused of assaulting woman in Dublin city
4 hrs ago
28.5k
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 160 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 110 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 142 partners can use this purpose
Use limited data to select advertising 112 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 133 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 59 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 37 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 92 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 99 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 88 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 69 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say